Evidence map›Paper›PMID 35556214›Full record

ReviewCurrent heart failure reports2022

Harnessing NAD

Akash Chakraborty, Keaton E Minor, Hina Lateef Nizami, Ying Ann Chiao, Chi Fung Lee

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current heart failure reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Sexually dimorphic effects of SARM1 deletion on cardiac NADAmerican journal of physiology. Heart and circulatory physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akash ChakrabortyCardiovascular Biology Research Program, MS 45, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.
Keaton E MinorCardiovascular Biology Research Program, MS 45, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.
Hina Lateef NizamiCardiovascular Biology Research Program, MS 45, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.
Ying Ann ChiaoAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Chi Fung LeeCardiovascular Biology Research Program, MS 45, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA. chifung-lee@omrf.org.ORCID 0000-0002-5395-6925

Funding

Viral sensor IFIH1 promotes SLE through an altered interferon programP20GM139763 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Rajanarayanan S Srinivasan · 2021 to 2026
$20.3M
Molecular Mechanisms of Rapamycin - Induced Reversal of Cardiac AgingR00AG051735 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CHIAO, YING ANN · 2019 to 2021
$747k
NIA NIH HHS R00 AG051735NIGMS NIH HHS P20 GM139763
6 · The paper itself

Abstract

purpose of the reviewThis review summarizes current understanding on the roles of nicotinamide adenine dinucleotide (NAD RECENT

findingsNAD

Indexed as

Heart DiseasesHeart FailureHumansNADOxidation-ReductionNADCardiometabolic diseasesHeart failureNAD+ metabolismRedox balance

Identifiers

PMID35556214
PMCPMC9339518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.